Journal of Pathology and Disease Biology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 1518081136

Mini Review - Journal of Pathology and Disease Biology (2023) Volume 7, Issue 2

Modern pathology: Understanding disease in the 21st century

Mohammed Zubair*

Department of Modern Pathology, Aga Khan University Hospital, Karachi, Pakistan

*Corresponding Author:
Mohammed Zubair
Department of Modern Pathology
Aga Khan University Hospital, Karachi, Pakistan
E-mail: zubair0712@gmail.com

Received: 24-Mar-2023, Manuscript No. AAPDB-23-92408; Editor assigned: 25-Mar-2023, PreQC No. AAPDB-23-92408(PQ); Reviewed: 09-Apr-2023, QC No. AAPDB-23-92408; Revised: 13-Apr-2023, Manuscript No. AAPDB-23-92408(R); Published: 20-Apr-2023, DOI:10.35841/2529-8046-7.2.140

Citation: Zubair M. Modern pathology: Understanding disease in the 21st century. J Pathol Dis Biol. 2023;7(2):140

Visit for more related articles at Journal of Pathology and Disease Biology

Pathology is the study of disease and its effects on the body, and has been an integral part of medicine since the earliest days of medical practice. Over the centuries, advances in technology and scientific understanding have led to significant progress in the field of pathology, and today we have an ever-growing understanding of the mechanisms behind disease at the cellular and molecular level. Modern pathology is a dynamic and rapidly-evolving field, utilizing a range of cutting-edge techniques and technologies to gain insights into the nature and behavior of disease. In this article, we will explore some of the key developments in modern pathology, and consider the implications of these advances for our understanding and treatment of disease in the 21st century [1].

One of the most important developments in modern pathology has been the use of genomics and other molecular technologies to study the underlying mechanisms of disease. These techniques allow researchers to analyze the genetic makeup of diseased cells, and to identify the specific genes and mutations that contribute to the development and progression of various diseases. For example, genomic sequencing has been used to identify mutations in the BRCA genes that are associated with a significantly increased risk of breast and ovarian cancer. This knowledge has led to the development of targeted therapies and preventive measures that can help individuals with these mutations to manage their risk of developing cancer [2].

In addition to genomics, modern pathology also relies heavily on imaging technologies to help diagnose and monitor disease. Advances in magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) have made it possible to create detailed images of the internal structures of the body, allowing physicians to detect abnormalities and changes in tissue that may indicate the presence of disease. Furthermore, many of these imaging technologies have been combined with molecular and cellular analyses to create powerful new tools for diagnosing and tracking disease. For example, PET-CT imaging can be used to detect the presence of cancer cells in the body, while also providing information on the metabolic activity and location of these cells. This can help physicians to determine the best course of treatment for individual patients, based on the unique characteristics of their disease [3].

Another important development in modern pathology has been the growing emphasis on personalized medicine. As our understanding of the genetic and molecular basis of disease has advanced, it has become increasingly clear that there is significant variation in the way different individuals respond to treatment. By tailoring treatment plans to the specific genetic and molecular characteristics of each patient's disease, physicians can achieve better outcomes and reduce the risk of adverse side effects. For example, recent studies have shown that patients with certain genetic mutations may respond better to immunotherapy for cancer than to traditional chemotherapy or radiation. The growing importance of personalized medicine is also reflected in the increasing use of biomarkers to diagnose and monitor disease. Biomarkers are molecular or cellular indicators of disease, which can be measured in blood or other bodily fluids. By tracking changes in biomarker levels over time, physicians can gain valuable insights into the progression of disease, and use this information to guide treatment decisions [4].

Finally, it is worth noting that modern pathology is not limited to the study of disease in humans. Veterinarians and animal scientists also rely heavily on pathology to understand and treat diseases in animals, and the insights gained from this research can have important implications for human health as well [5].

In conclusion, modern pathology is a diverse and rapidlyevolving field, encompassing a wide range of techniques and technologies for studying disease at the cellular and molecular level. From genomics and imaging to personalized medicine and cross-species research, the insights gained from modern pathology are shaping the way we understand and treat disease in the 21st century. Modern pathology is a dynamic and rapidly-evolving field that is playing an increasingly important role in our understanding and treatment of disease in the 21st century. From genomics and imaging to personalized medicine and cross-species research, the insights gained from modern pathology are shaping the way we approach and treat disease, and offering new hope to patients around the world. With the continued development of new technologies and techniques, it is likely that the field of pathology will continue to make significant advances in the years and decades to come.

References

  1. Moran JM, Le LP, Nardi V, et al. Identification of fusions with potential clinical significance in melanoma. Modern Pathol. 2022;35(12):1837-47.

    2. Indexed at, Google Scholar, Cross Ref

  2. Pai RK, Bettington M, Srivastava A, et al. An update on the morphology and molecular pathology of serrated colorectal polyps and associated carcinomas. Modern Pathol. 2019;32(10):1390-415.

    3. Indexed at, Google Scholar, Cross Ref

  3. Hanna MG, Ardon O, Reuter VE, et al. Integrating digital pathology into clinical practice. Modern Pathol. 2022;35(2):152-64.

    4. Indexed at, Google Scholar, Cross Ref

  4. Thompson EF, Huvila J, Jamieson A, et al. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification. Modern Pathol. 2022;35(12):1974-82.

    5. Indexed at, Google Scholar, Cross Ref

  5. Hanna MG, Ardon O, Reuter VE, et al. Correction: Integrating digital pathology into clinical practice. Modern Pathol. 2022;35(2):286.

    6. Indexed at, Google Scholar, Cross Ref

Get the App